NY-ESO-1 antibody as a novel tumour marker of gastric cancer

被引：0
|
作者：
S Fujiwara
H Wada
J Kawada
R Kawabata
T Takahashi
J Fujita
T Hirao
K Shibata
Y Makari
S Iijima
H Nishikawa
A A Jungbluth
Y Nakamura
Y Kurokawa
M Yamasaki
H Miyata
K Nakajima
S Takiguchi
E Nakayama
M Mori
Y Doki
机构：
[1] Graduate School of Medicine,Department of Gastroenterological Surgery
[2] Osaka University,Department of Experimental Immunology
[3] 2-2 Yamadaoka,undefined
[4] Suita-city (E-2),undefined
[5] Osaka 565-0871,undefined
[6] Japan,undefined
[7] Surgery,undefined
[8] Toyonaka Municipal Hospital,undefined
[9] Surgery,undefined
[10] Ikeda City Hospital,undefined
[11] Surgery,undefined
[12] Minoh City Hospital,undefined
[13] Immunology Frontier Research Center,undefined
[14] Osaka University,undefined
[15] 3-1 Yamadaoka,undefined
[16] Suita-city,undefined
[17] Osaka 565-0871,undefined
[18] Japan,undefined
[19] Ludwig Institute for Cancer Research,undefined
[20] New York Branch at Memorial Sloan-Kettering Cancer Center,undefined
[21] Faculty of Health and Welfare,undefined
[22] Kawasaki University of Medical Welfare,undefined
来源：
British Journal of Cancer | 2013年 / 108卷
关键词：
surgical treatment; detection marker; follow-up marker; recurrence; prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1119 / 1125
页数：6
相关论文
共 50 条
  • [41] Current advances in cancer vaccines targeting NY-ESO-1 for solid cancer treatment
    Zhou, Hong
    Ma, Yipeng
    Liu, Fenglan
    Li, Bin
    Qiao, Dongjuan
    Ren, Peigen
    Wang, Mingjun
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [42] NY-ESO-1: a promising cancer testis antigen for sarcoma immunotherapy and diagnosis
    Smith, Stephen M.
    Iwenofu, O. Hans
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (04)
  • [43] NY-ESO-1 protein expression and humoral immune responses in prostate cancer
    Fosså, A
    Berner, A
    Fosså, SD
    Hernes, E
    Gaudernack, G
    Smeland, EB
    PROSTATE, 2004, 59 (04): : 440 - 447
  • [44] NY-ESO-1 protein cancer vaccine with TLR 3 and 4 agonists
    Takeoka, Tomohira
    Nagase, Hirotsugu
    Miyazaki, Yasuhiro
    Takahashi, Tsuyoshi
    Kurokawa, Yukinori
    Makino, Tomoki
    Yamasaki, Makoto
    Takiguchi, Shuji
    Mori, Masaki
    Doki, Yuichiro
    Wada, Hisashi
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [45] WT1, NY-ESO-1 AND PRAME EXPRESSION IN BREAST CANCER SUBTYPES
    Esposito, A.
    Bagnardi, V.
    Criscitiello, C.
    Gelao, L.
    Viale, G.
    Curigliano, G.
    ANNALS OF ONCOLOGY, 2014, 25 : 18 - 18
  • [46] Strategically Comprehensive Immunotherapy Employing Modified Antibody Targeting NY-ESO-1 for Multiple Myeloma
    Maruta, Masaki
    Tanimoto, Kazushi
    Azuma, Taichi
    Fujiwara, Hiroshi
    Yasukawa, Masaki
    CANCER SCIENCE, 2018, 109 : 757 - 757
  • [47] A Potential Role for Immunotherapy in Thyroid Cancer by Enhancing NY-ESO-1 Cancer Antigen Expression
    Gunda, Viswanath
    Frederick, Dennie T.
    Bernasconi, Maria J.
    Wargo, Jennifer A.
    Parangi, Sareh
    THYROID, 2014, 24 (08) : 1241 - 1250
  • [48] 肿瘤抗原NY-ESO-1的研究现状
    张行炜
    黄辉
    邵益森
    南昌大学学报(医学版), 2010, 50 (07) : 120 - 122
  • [49] 肿瘤抗原NY-ESO-1研究进展
    高丹
    徐帆洪
    国际生物制品学杂志, 2008, (04) : 181 - 185
  • [50] NY-ESO-1 Expression Is Associated with Melanoma Thickness, but Not Mortality
    Giavina-Bianchi, Mara
    Sotto, Miriam Nacagamo
    Kanashiro, Luciane
    Simpson, Andrew J.
    Giavina-Bianchi, Pedro
    Kalil, Jorge
    Festa, Cyro
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB66 - AB66
12345